February 27, 2026

Syndax Pharmaceuticals, Inc. (SNDX)

⚠️ No article content returned.

..

LifeMD, Inc. (LFMD) Investor Outlook: Exploring a 232.73% Potential Upside

LifeMD, Inc. (NASDAQ: LFMD) is drawing significant attention from investors, and for good reason. With a potential upside of 232.73% based on its current trading price of $2.78 and an..

Mind Medicine Inc. (MNMD) Stock Analysis: Exploring Potential Upside in a Transformative Biotech

Mind Medicine (MindMed) Inc. (MNMD), a pioneering name in the biotechnology landscape, is increasingly capturing the attention of investors keen on exploring the burgeoning field of psychedelic medicine for brain..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Unveiling a 74% Potential Upside in the Biotech Sector

Bicara Therapeutics Inc. (NASDAQ: BCAX) is making waves in the biotech sector with a compelling investment narrative. With a market capitalization of approximately $920.34 million, this Boston-based company is focused..

Evolus, Inc. (EOLS) Stock Analysis: A 237% Potential Upside in the Healthcare Sector

Evolus, Inc. (NASDAQ: EOLS) is capturing investor attention with its remarkable potential upside of 237.79%, as highlighted by recent analyst ratings. Specializing in the performance beauty industry, Evolus is making..

iRadimed Corporation (IRMD) Stock Analysis: A Promising 17% Upside in the Medical Devices Industry

For investors seeking opportunities in the healthcare sector, iRadimed Corporation (NASDAQ: IRMD) stands out as a promising option. As a notable player in the medical devices industry, iRadimed specializes in..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth with Caution Amid Potential Downside

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, operates at the intersection of animal health and mineral nutrition. With its headquarters in Teaneck, New Jersey,..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech Gem with 279% Potential Upside

LENZ Therapeutics, Inc. (NASDAQ: LENZ) has captured the attention of investors with its promising focus on improving vision through innovative therapies. Situated in the dynamic biotechnology sector, LENZ is headquartered..

STAAR Surgical (STAA) Stock Report: Navigating a 11.84% Potential Upside Amidst Volatile Metrics

STAAR Surgical Company (NASDAQ: STAA), a notable player in the medical instruments and supplies industry, is capturing investor attention with a potential upside of 11.84%. Based in Lake Forest, California,..

Zymeworks Inc. (ZYME) Stock Analysis: A High Upside Prospect with Promising Biotech Innovations

Zymeworks Inc. (NASDAQ: ZYME) is gaining attention in the biotech sector with a market cap of $1.81 billion. The company, which is headquartered in Middletown, Delaware, is a clinical-stage biotechnology..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Evaluating a Potential 46.86% Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, has recently caught the attention of investors with a notable potential upside of 46.86%. As a biopharmaceutical company..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 38.57% Upside Potential

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specifically in medical devices, is drawing investor attention with its compelling growth potential. Headquartered in Lewisville, Texas, Orthofix..

CureVac N.V. (CVAC) Investor Outlook: Analyzing the Biotech’s Future Amid Major Acquisition

CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, has recently attracted significant attention due to its acquisition by BioNTech SE. With a market capitalization of $1.05 billion,..

Immatics N.V. (IMTX) Stock Analysis: Potential 91% Upside Amid Strong Buy Ratings

Immatics N.V. (NASDAQ: IMTX), a biotechnology frontrunner in the healthcare sector, is capturing investor attention with its ambitious pipeline of cancer immunotherapies. Headquartered in Tübingen, Germany, the company is at..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges in the Medical Device Sector

Avanos Medical, Inc. (NYSE: AVNS) is a player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of $672.61 million, this US-based company is..

Nurix Therapeutics, Inc. (NRIX): Biotechnology Innovator with 86% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is capturing attention in the biotechnology sector, primarily due to its promising drug development pipeline and a potential upside of 86.22%, as indicated by current..

Cronos Group Inc. (CRON): Investor Outlook on a Cannabis Pioneer with 47% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON) is a name that resonates with many investors interested in the burgeoning cannabis market. As a key player in the healthcare sector, specifically within the..

Butterfly Network, Inc. (BFLY) Stock Analysis: Innovative Medical Devices with a Potential 8.40% Upside

For investors seeking to tap into the burgeoning medical devices sector, Butterfly Network, Inc. (NYSE: BFLY) presents an intriguing opportunity. With its market cap sitting at $1.18 billion, this healthcare..

Embecta Corp. (EMBC) Stock Analysis: Attractive Dividend Yield and Significant Upside Potential Beckon Investors

Embecta Corp. (EMBC), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. The company is renowned for its diabetes care solutions, including pen needles, syringes,..

Zevra Therapeutics, Inc. (ZVRA) Investor Outlook: Uncovering a Potential 148% Upside in the Biotech Sector

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has been turning heads in the biotechnology sector with its focus on rare diseases and promising product pipeline. With a market capitalization of $511.74 million,..

Search

Funds

February 27, 2026

Search

Funds

February 27, 2026

FTSE 100

Funds